2003
DOI: 10.3310/hta7330
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review

Abstract: Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
5

Year Published

2005
2005
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 107 publications
(30 citation statements)
references
References 51 publications
1
24
0
5
Order By: Relevance
“…Det finnes en randomisert studie som sammenligner brachyterapi og prostatektomi (Buron et al, 2007). Tidligere systematiske gjennomganger har imidlertid ikke kunnet vise tilstrekkelig evidens til å kunne veie total og sykdomsspesifikk overlevelse ved brachyterapi opp mot andre radikale teknikker (Hummel et al, 2003,Norderhaug et al, 2003,Doust et al, 2004,Nilsson et al, 2004. For lavrisikogruppen synes det å vaere lik biokjemisk residivfri overlevelse mellom ekstern strålebehandling, brachyterapi og radikal prostatektomi.…”
Section: Lavdoserateunclassified
“…Det finnes en randomisert studie som sammenligner brachyterapi og prostatektomi (Buron et al, 2007). Tidligere systematiske gjennomganger har imidlertid ikke kunnet vise tilstrekkelig evidens til å kunne veie total og sykdomsspesifikk overlevelse ved brachyterapi opp mot andre radikale teknikker (Hummel et al, 2003,Norderhaug et al, 2003,Doust et al, 2004,Nilsson et al, 2004. For lavrisikogruppen synes det å vaere lik biokjemisk residivfri overlevelse mellom ekstern strålebehandling, brachyterapi og radikal prostatektomi.…”
Section: Lavdoserateunclassified
“…This model is similar to the model used by Hummel et al and Fleming et al to evaluate different treatments for prostate carcinoma. 8,9 The allowable state transitions were from no disease progression, to hormone-responsive disease progression, to hormone-unresponsive disease progression, to death. The transitions from states of no disease progression to states of hormone-responsive and hormone-nonresponsive disease progression were biochemical determinations.…”
Section: Decision Modelmentioning
confidence: 99%
“…El tratamiento convencional del Cap localizado incluye la actitud de vigilancia expectante, la prostatectomía radical (retropúbica abierta o laparoscópica, perineal) y la radioterapia 2 . Todas estas opciones pueden producir efectos secundarios no deseados, como la incontinencia urinaria y la disfunción eréctil.…”
Section: Introducción Y Antecedentesunclassified